| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1155/2012/320495 |
| P8608 | Fatcat ID | release_ftfxusnqsfhy5hoohd7ropk2oy |
| P932 | PMC publication ID | 3480695 |
| P698 | PubMed publication ID | 23118504 |
| P5875 | ResearchGate publication ID | 232766300 |
| P2093 | author name string | Jennifer L. McRae | |
| Joanne S. J. Chia | |||
| Karen M. Dwyer | |||
| Peter J. Cowan | |||
| P2860 | cites work | Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia | Q24817161 |
| Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies | Q28196175 | ||
| The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. | Q64895051 | ||
| The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice | Q72822590 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease | Q80141838 | ||
| A1 receptor deficiency causes increased insulin and glucagon secretion in mice | Q81297403 | ||
| Improved blood glucose disposal and altered insulin secretion patterns in adenosine A(1) receptor knockout mice | Q84052940 | ||
| Adenosine signaling promotes regeneration of pancreatic β cells in vivo | Q42197940 | ||
| Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury | Q42199760 | ||
| Effects of an adenosine-receptor antagonist on insulin-resistance in soleus muscle from obese Zucker rats | Q42847859 | ||
| Reversal of dietary-induced insulin resistance in muscle of the rat by adenosine deaminase and an adenosine-receptor antagonist | Q42848477 | ||
| Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion | Q43242952 | ||
| Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance | Q43795785 | ||
| NTPDase and 5'-nucleotidase activities in rats with alloxan-induced diabetes | Q44910861 | ||
| The impact of purinergic signaling on renal ischemia-reperfusion injury | Q46185587 | ||
| Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors | Q46694898 | ||
| Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury | Q46962262 | ||
| Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. | Q50849047 | ||
| Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. | Q51374940 | ||
| The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. | Q53556059 | ||
| Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury | Q57708452 | ||
| CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation | Q61612314 | ||
| Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 | ||
| Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication | Q28568760 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans | Q30428503 | ||
| Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma | Q30439604 | ||
| ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell | Q33778734 | ||
| Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation | Q33784839 | ||
| Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin | Q34082851 | ||
| T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine | Q34578972 | ||
| Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line | Q34613096 | ||
| Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. | Q34621389 | ||
| The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance | Q34769236 | ||
| Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. | Q34769242 | ||
| Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia | Q34797847 | ||
| Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart | Q35025385 | ||
| Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity | Q35067242 | ||
| Impaired glucose tolerance in the absence of adenosine A1 receptor signaling | Q35227208 | ||
| Introduction to adenosine receptors as therapeutic targets | Q36153376 | ||
| The P2Y(1) receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice | Q36173756 | ||
| Adenosine receptor activation ameliorates type 1 diabetes. | Q36427003 | ||
| Physiological roles for ecto-5'-nucleotidase (CD73). | Q36478279 | ||
| Deletion of cd39/entpd1 results in hepatic insulin resistance | Q36842553 | ||
| Evidence for the possible involvement of the P2Y(6) receptor in Ca (2+) mobilization and insulin secretion in mouse pancreatic islets | Q36973397 | ||
| Central role of Sp1-regulated CD39 in hypoxia/ischemia protection | Q37039131 | ||
| Purinergic receptors in the endocrine and exocrine pancreas. | Q37119875 | ||
| Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease | Q37141784 | ||
| A2B adenosine receptor dampens hypoxia-induced vascular leak | Q37336475 | ||
| Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism | Q38337539 | ||
| Identification of the ectonucleotidases expressed in mouse, rat, and human Langerhans islets: potential role of NTPDase3 in insulin secretion. | Q39671882 | ||
| CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes | Q39990373 | ||
| Dexamethasone inhibits proliferation and stimulates ecto-5'-nucleotidase/CD73 activity in C6 rat glioma cell line | Q40142178 | ||
| The impact of adenosine and A(2B) receptors on glucose homoeostasis | Q40164891 | ||
| Metabolic coupling factors in pancreatic beta-cell signal transduction | Q40422075 | ||
| Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages | Q40488434 | ||
| Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets | Q40718427 | ||
| CD39 and control of cellular immune responses | Q40730152 | ||
| Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. | Q41985015 | ||
| Evidence for an A2-subtype adenosine receptor on pancreatic glucagon secreting cells | Q42109553 | ||
| Glucose decreases extracellular adenosine levels in isolated mouse and rat pancreatic islets. | Q42182907 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| heterocyclic compound | Q193430 | ||
| pathogenesis | Q372016 | ||
| signal transduction | Q828130 | ||
| enzyme | Q8047 | ||
| type 2 diabetes | Q3025883 | ||
| apyrase family | Q24770179 | ||
| CD antigens | Q66660268 | ||
| P304 | page(s) | 320495 | |
| P577 | publication date | 2012-01-01 | |
| 2012-10-14 | |||
| P1433 | published in | Journal of Biomedicine and Biotechnology | Q15752146 |
| P1476 | title | The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes | |
| P478 | volume | 2012 |
| Q38358000 | Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations |
| Q91654961 | Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease |
| Q34703746 | Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states |
| Q42372999 | Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent Retina |
| Q31170140 | Integrating genomic data from high-throughput studies with computational modeling reveals differences in the molecular basis of hyposalivation between type 1 and type 2 diabetes |
| Q35436829 | Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice |
| Q55261560 | The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases. |
Search more.